Strongyloidiasis in transplant patients

Clinical Infectious Diseases

Volumn 49, Issue 9, 2009, Pages 1411-1423

  Roxby , Alison C ^a   Gottlieb , Geoffrey S ^a   Limaye, Ajit P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; IVERMECTIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TIABENDAZOLE;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BLOOD CELL COUNT; BRONCHOSCOPY; CLINICAL TRIAL; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; EOSINOPHIL COUNT; FECES ANALYSIS; GASTROINTESTINAL ENDOSCOPY; GEOGRAPHIC DISTRIBUTION; GRAFT VERSUS HOST REACTION; HEART FAILURE; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUNG LAVAGE; MORTALITY; NASOGASTRIC TUBE; ORTHOTOPIC TRANSPLANTATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECOMMENDED DRUG DOSE; RESPIRATORY DISTRESS; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SKIN BIOPSY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THORAX RADIOGRAPHY;

ANIMALS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 72849121083     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/630201     Document Type: Review

References (68)

1. Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am 1993; 7:655-682
2. Gill GV, Beeching NJ, Khoo S, et al. A British Second World War veteran with disseminated strongyloidiasis. Trans R Soc Trop Med Hyg 2004; 98:382-386 (Pubitemid 38950399)
3. Olsen A, van Lieshout L, Marti H, et al. Strongyloidiasis-the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg 2009; published online March 26.
4. Ungar BL, Iscoe E, Cutler J, Bartlett JG. Intestinal parasites in amigrant farmworker population. Arch Intern Med 1986; 146:513-515 (Pubitemid 16067898) (Pubitemid 16067898)
5. Berk SL, Verghese A, Alvarez S, Hall K, Smith B. Clinical and epidemiologic features of strongyloidiasis: a prospective study in rural Tennessee. Arch Intern Med 1987; 147:1257-1261 (Pubitemid 17102153) (Pubitemid 17102153)
6. Buchwald D, Lam M, Hooton TM. Prevalence of intestinal parasites and association with symptoms in Southeast Asian refugees. J Clin Pharm Ther 1995; 20:271-275
7. Roman-Sanchez P, Pastor-Guzman A, Moreno-Guillen S, Igual-Adell R, Suner-Generoso S, Tornero-Estebanez C. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg 2003; 69:336-340
8. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33:1040-1047
9. Prociv P, Luke R. Observations on strongyloidiasis in Queensland aboriginal communities. Med J Aust 1993; 158:160-163 (Pubitemid 23094580)
10. Steinmann P, Zhou XN, Du ZW, et al. Occurrence of Strongyloides stercoralis in Yunnan Province, China, and comparison of diagnostic methods. PLoS Negl Trop Dis 2007; 1:e75.
11. Mandell GL, Douglas RG, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennetts principles and practice of infectious diseases. 6th ed. New York: Elsevier/Churchill Livingstone, 2005.
12. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17:208-217
13. Mahmoud AA. Strongyloidiasis. Clin Infect Dis 1996; 23:949-52; quiz 53.
14. Igra-Siegman Y, Kapila R, Sen P, Kaminsky ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981; 3: 397-407.
15. Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg 2008; 102:314-318
16. Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy 2006; 4:8.
17. Fardet L, Genereau T, Poirot JL, Guidet B, Kettaneh A, Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect 2007; 54:18-27. (Pubitemid 44932945)
18. Schad GA. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis 1986; 153:178.
19. Palau LA, Pankey GA. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 1997; 57:413-415
20. Nolan TJ, Schad GA. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation 1996; 62:1038.
21. Fagundes LA, Busato O, Brentano L. Strongyloidiasis: fatal complication of renal transplantion. Lancet 1971; 2:439-440
22. DeVault GA Jr, King JW, Rohr MS, Landreneau MD, Brown ST 3rd, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990; 12:653-671
23. Soman R, Vaideeswar P, Shah H, Almeida AF. A 34-year-old renal transplant recipient with high-grade fever and progressive shortness of breath. J Postgrad Med 2002; 48:191-196 (Pubitemid 35390325)
24. Tarr P, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003; 68:453-455 (Pubitemid 38230646)
25. Prasad N, Ram R, Satti Reddy V, Dakshinamurty KV. Non-fatal gastric mucormycosis in a renal transplant patient and review of the literature. Transpl Infect Dis 2006; 8:237-241 (Pubitemid 44787866) (Pubitemid 44787866)
26. Valar C, Keitel E, Dal Prá RL, et al. Parasitic infection in renal transplant recipients. Transplant Proc 2007; 39:460-462 (Pubitemid 46415621)
27. Said T, Nampoory MR, Nair MP, et al. Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait. Transplant Proc 2007; 39:1014-1015 (Pubitemid 46764886)
28. Morrell MR, Dallas J, Kollef MH. A 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantation. Chest 2008; 134:442-446
29. Huston JM, Eachempati SR, Rodney JR, et al. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. Transpl Infect Dis 2009; 11:277-280
30. El Masry HZ, ODonnell J. Fatal Strongyloides hyperinfection in heart transplantation. J Heart Lung Transplant 2005; 24:1980-1983
31. Schaeffer MW, Buell JF, Gupta M, Conway GD, Akhter SA, Wagoner LE. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant 2004; 23:905-911 (Pubitemid 38953877)
32. Mizuno S, Lida T, Zendejas I, et al. Strongyloides hyperinfection syndrome following simultaneous heart and kidney transplantation. Transpl Int 2009; 22:251-253
33. Vilela EG, Clemente WT, Mira RR, et al. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transpl Infect Dis 2009; 11:132-136
34. Lichtenberger P, Rosa-Cunha I, Morris M, et al. Hyperinfection strongyloidiasis in a liver transplant patient treated with parenteral ivermectin. Transpl Infect Dis 2009; 11:137-142
35. Patel G, Arvelakis A, Sauter BV, Gondolesi GE, Caplivski D, Huprikar S. Strongyloides hyperinfection syndrome after intestinal transplantation. Transpl Infect Dis 2008; 10:137-141
36. Ben-Youssef R, Baron P, Edson F, Raghavan R, Okechukwu O. Strongyloides stercoralis infection from pancreas allograft: case report. Transplantation 2005; 80:997-998 (Pubitemid 41552900) (Pubitemid 41552900)
37. Balagopal A, Mills L, Shah A, Subramanian A. Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. Transpl Infect Dis 2009; 11:149-154
38. Wirk B, Wingard JR. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis 2009; 11:143-148
39. Steiner B, Riebold D, Wolff D, Freund M, Reisinger EC. Strongyloides stercoralis eggs in a urethral smear after bone marrow transplantation. Clin Infect Dis 2002; 34:1280-1281 (Pubitemid 34450681) (Pubitemid 34450681)
40. Orlent H, Crawley C, Cwynarski K, Dina R, Apperley J. Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 32:115-117 (Pubitemid 36850290) (Pubitemid 36850290)
41. Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004; 100:1531-1536
42. Gupta S, Jain A, Fanning TV, Couriel DR, Jimenez CA, Eapen GA. An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report. BMC Cancer 2006; 6:87. (Pubitemid 43885030) (Pubitemid 43885030)
43. Qazilbash MH, Ueno NT, Hosing C, et al. Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 38:393-394 (Pubitemid 44241553)
44. Dulley FL, Costa S, Cosentino R, Gamba C, Saboya R. Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantation. Bone Marrow Transplant 2009; 43:741-742
45. Hoy WE, Roberts NJ Jr, Bryson MF, et al. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA 1981; 246:1937-1939
46. Boulware DR, Stauffer WM, Hendel-Paterson BR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-intraining survey. Am J Med 2007; 120:545.e1-8
47. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2004; 4(Suppl 10):10-20.
48. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Recomm Rep 2000; 49: 1-125.
49. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995; 53: 248-250
50. Hirata T, Nakamura H, Kinjo N, et al. Increased detection rate of Strongyloides stercoralis by repeated stool examinations using the agar plate culture method. Am J Trop Med Hyg 2007; 77:683-684 (Pubitemid 351844292)
51. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a nonendemic area. Am J Trop Med Hyg 2002; 66:749-752 (Pubitemid 35001049)
52. Ramanathan R, Burbelo PD, Groot S, Iadarola MJ, Neva FA, Nutman TB. A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis 2008; 198:444-451
53. Verweij JJ, Canales M, Polman K, et al. Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg 2009; 103:342-346
54. DeVault GA Jr, Brown ST 3rd, Montoya SF Jr, King JW, Rohr MS, McDonald JC. Disseminated strongyloidiasis complicating acute renalallograft rejection: prolonged thiabendazole administration and successful retransplantation. Transplantation 1982; 34:220-221
55. Ashraf M, Gue CL, Baddour LM. Case report: strongyloidiasis refractory to treatment with ivermectin. Am J Med Sci 1996; 311:178-179 (Pubitemid 126425631)
56. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004; 26:487-497 (Pubitemid 40461165) (Pubitemid 40461165)
57. Parasitic infections. Am J Transplant 2004; 4(Suppl 10):142-155
58. Gann PH, Neva FA, Gam AA. A randomized trial of single- and twodose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169:1076-1079
59. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88:344-345 (Pubitemid 24206464) (Pubitemid 24206464)
60. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother 2007; 41:1992-2001. (Pubitemid 350230567) (Pubitemid 350230567)
61. Zaha O, Hirata T, Kinjo F, Saito A, Fukuhara H. Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart. J Infect Chemother 2002; 8:94-98 (Pubitemid 34456587)
62. Fowler CG, Lindsay I, Levin J, Sweny P, Fernando ON, Moorhead JF. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) 1982; 285:1394. (Pubitemid 13230015)
63. Page WA, Dempsey K, McCarthy JS. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg 2006; 100:1056-1062 (Pubitemid 44309207)
64. Udall DN. Recent updates on onchocerciasis: diagnosis and treatment. Clin Infect Dis 2007; 44:53-60. (Pubitemid 44968984) (Pubitemid 44968984)
65. Marty FM, Lowry CM, Rodriguez M, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005; 41:e5-8.
66. Turner SA, Maclean JD, Fleckenstein L, Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg 2005; 73:911-914 (Pubitemid 41688467)
67. Pacanowski J, Santos MD, Roux A, et al. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005; 73:122-124 (Pubitemid 41278760)
68. Morgan JS, Schaffner W, Stone WJ. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation 1986; 42:518-524 (Pubitemid 17196077)